BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9988400)

  • 1. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.
    Agrawal R; Tan SL; Wild S; Sladkevicius P; Engmann L; Payne N; Bekir J; Campbell S; Conway G; Jacobs H
    Fertil Steril; 1999 Feb; 71(2):287-93. PubMed ID: 9988400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
    Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H
    Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of free vascular endothelial growth factor(165) (VEGF(165)) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls.
    Enskog A; Nilsson L; Brännström M
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):196-201. PubMed ID: 11384807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program.
    Artini PG; Fasciani A; Monti M; Luisi S; D'Ambrogio G; Genazzani AR
    Fertil Steril; 1998 Sep; 70(3):560-4. PubMed ID: 9757891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization.
    Lee A; Christenson LK; Stouffer RL; Burry KA; Patton PE
    Fertil Steril; 1997 Aug; 68(2):305-11. PubMed ID: 9240261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration.
    Ludwig M; Jelkmann W; Bauer O; Diedrich K
    Hum Reprod; 1999 Oct; 14(10):2437-41. PubMed ID: 10527964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
    Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception.
    Mathur R; Hayman G; Bansal A; Jenkins J
    Fertil Steril; 2002 Dec; 78(6):1154-8. PubMed ID: 12477503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.
    Ludwig M; Bauer O; Lopens A; Jelkmann W; Diedrich K
    Hum Reprod; 1998 Jan; 13(1):30-2. PubMed ID: 9512224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.
    D'Ambrogio G; Fasciani A; Monti M; Cattani R; Genazzani AR; Artini PG
    Gynecol Endocrinol; 1999 Oct; 13(5):311-5. PubMed ID: 10599547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
    Wang Q; Yang G; Yang C; Zhan B; Yang R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome.
    Chen CD; Chen HF; Lu HF; Chen SU; Ho HN; Yang YS
    Hum Reprod; 2000 May; 15(5):1037-42. PubMed ID: 10783347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
    Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome.
    Ogawa S; Minakami H; Araki S; Ohno T; Motoyama M; Shibahara H; Sato I
    J Assist Reprod Genet; 2001 Feb; 18(2):114-9. PubMed ID: 11285978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in serum vascular endothelial growth factor binding profiles and the development of ovarian hyperstimulation syndrome.
    McElhinney B; Ardill J; Caldwell C; Lloyd F; McClure N
    Fertil Steril; 2002 Aug; 78(2):286-90. PubMed ID: 12137864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome.
    Artini PG; Monti M; Fasciani A; Battaglia C; D'Ambrogio G; Genazzani AR
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):169-74. PubMed ID: 11858893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.